Viewing Study NCT03844750

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:06 PM
Ignite Modification Date: 2026-01-24 @ 6:17 PM
Study NCT ID: NCT03844750
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-11
First Post: 2019-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
Sponsor: Chloe Atreya, MD, PhD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Malignant Neoplasm in the Liver View
None Stage IV Colorectal Cancer AJCC v8 View
None Stage IVA Colorectal Cancer AJCC v8 View
None Stage IVB Colorectal Cancer AJCC v8 View
None Stage IVC Colorectal Cancer AJCC v8 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Resectable hepatic metastases View
None Surgery View
None Immunotherapy View
None Adjuvant Treatment View